EXC vs TERN · P/E 17, rev $23.03B vs $6.12B cap
Exelon Corporation (EXC) versus Terns Pharmaceuticals Inc (TERN) — a side-by-side from cached financials, not a winner call.
Exelon Corporation (EXC) is a utilities - regulated electric company listed on NASDAQ.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Latest reported EXC revenue for 2024-12-31 was $23.03B. Net income was $2.46B. Revenue was up 6.0% from 2023-12-31 to 2024-12-31. EXC currently screens at market cap $47.33B and trailing P/E 16.8.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
EXC currently screens at market cap $47.33B and trailing P/E 16.8. TERN currently screens at market cap $6.12B.
Not investment advice. Open the EXC and TERN stock pages for the full models.
Not investment advice.